Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
Berger
Alan R
AR
Department of Neurology, University of Florida, USA.
Bradley
Walter G
WG
Brannagan
Thomas H
TH
Busis
Neil A
NA
Cros
Didier P
DP
Dalakas
Marinos C
MC
Danon
Moris J
MJ
Donofrio
Peter
P
Engel
W King
WK
England
John D
JD
Feldman
Eva L
EL
Freeman
Roy L
RL
Kinsella
Laurence J
LJ
Lacomis
David
D
Latov
Norman
N
Menkes
Daniel L
DL
Sander
Howard W
HW
Thomas
Florian P
FP
Triggs
William J
WJ
Windebank
Anthony J
AJ
Wolfe
Gil I
GI
D003711:Demyelinating Diseases; D003929:Diabetic Neuropathies / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000628:therapy*; D019054:Evoked Potentials, Motor; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018482:Muscle, Skeletal / Q000503:physiopathology; D009413:Nerve Fibers, Myelinated / Q000502:physiology; D009431:Neural Conduction; D010951:Plasma Exchange / Q000379:methods; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000628:therapy*; D011930:Reaction Time; D018582:Sick Leave
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents